Thank You

Error.

With the broader stock market still trending up despite Wednesday's fallback, many investors seem intent on finding stocks that haven't joined the rally.

In a piece for The Street, founder and CNBC pundit Jim Cramer argues that energy stocks, which have lagged the stock market this year, could be "the next to jump." And Cramer is taking a broad-based view of the sector.

He adds that the sector seems right for rotation and appreciation. "How long can this [energy-stock] underperformance last if the dollar stays weak," Cramer wonders.

He has an interesting point. Investments in energy and other commodities tend to gain value when the dollar weakens. And in recent weeks, the greenback, after gaining in value for months relative to the world's currencies, has lost strength as markets have determined that U.S. interest rates and economic growth should remain low. The price of oil has gained during this period.

StreetAuthority also weighs in with a bullish look at an industrial stock that is off most investors' radar:
W.W. GraingerGWW 1.2304938754963923%W.W. Grainger Inc.U.S.: NYSEUSD180.99
2.21.2304938754963923%
/Date(1506459609893-0500)/
Volume (Delayed 15m)
:
799629AFTER HOURSUSD179.6461
-1.34390000000002-0.7425272114481463%
Volume (Delayed 15m)
:
1791
P/E Ratio
20.899538106235564Market Cap
10314573840.957
Dividend Yield
2.828885573788607% Rev. per Employee
399351More quote details and news »GWWinYour ValueYour ChangeShort position
(GWW). The company is a distributor of maintenance, repair and operations supplies for businesses and institutions primarily in the U.S. and Canada.

StreetAuthority

"This company is growing at a 10% rate and is poised to generate impressive returns for the foreseeable future. It has also raised its dividend 41 straight years, offering a great blend of growth and income with less volatility than most stocks in the industrial sector," writes StreetAuthority's Jay Peroni.

The stock, which sports a 1.5% dividend yield, has consistently outperformed the broader market over the last two and five year periods. And even though industrial stocks have lagged the Standard & Poor's 500 in recent months, this stock has been an outperformer.

This may be a stock that's been hiding in plain sight. Read the story to learn more about it.

I've been writing this column for almost three months, and this is the first time I've written about biotechs. That's been an oversight. The sector has been a major outperformer this year.

24/7 Wall St.

"For value-oriented investors, these still need to soften up in price," writes Ogg. "For investors who chase growth at any price, there is still some perceived upside. The good news is that biotechs have pulled back and now Big Pharma stocks have all pulled back. The bad news is that if the market does not keep rising, it is very likely that investors will look for more patient entry points before chasing these high gains and valuations in biotech."

Ogg's argument is a bit wishy-washy. We'll take it as a sign that these stocks need to fall back a bit before they are worth buying.

One of the offerings, Apple's 10-year debt due in May 2023, was priced to yield 2.415%.

But as the FT's Lex column points out, there are reasons for investors in these bonds to be cautious. "Buying bonds at the record-low interest rates and long maturities that make it attractive for Apple to borrow leaves investors vulnerable to price declines when rates rise."